-
Please share with us three of your current concerns, Mr. Nishi.
-
AjiPro®-L has been designated as the poster child of the animal nutrition business’ specialty products, but there seems to be some difference between your forecasts for its profit contribution and actual results. How do you plan to close this gap in the future? Is there some difference between your perception of the market and real market conditions?
-
Competition in China’s animal nutrition market looks unlikely to change for the foreseeable future. What is your view of the Chinese market environment?
-
On a local currency basis, what level of growth are you expecting from your international seasonings and processed foods business in FY2016?
-
Has deterioration of Brazil’s economy resulted in any changes in demand for Ajinomoto products in that country?
-
Regarding fermented vanillin, which you have been developing together with T.Hasegawa Co., Ltd., why are consumers increasingly preferring natural flavorings? Also, as a business model, do you want to sell flavorings alone or do you want to use them to increase the value-added of your own products.
-
How do you plan to turn around the Thai beverage business? I hope to hear a convincing explanation.
-
What are the bottlenecks to improving profitability in the Japan market, where low growth is now the norm. And what kind of measures are needed to remove those bottlenecks?
-
You have pulled off a number of M&A deals in recent years. Is this success related to some positive effect from delegation of authority to a local subsidiary?
-
I understand you are promoting the Ajinomoto Group Shared Value (ASV) concept within and outside the company. Is this initiative producing any unexpected secondary effects?
-
Considering past examples in pharmaceuticals and sweeteners, I think there is a possibility for you to use joint ventures to achieve restructuring of the animal nutrition business. In that case, I assume you will have to share your technologies with the joint venture partner. What risks would that pose?
-
Changing product packaging has been mentioned as one strategy for dealing with Ajinomoto brands imitations in Myanmar, but do you really regard that as a fundamental solution? Imitation products could just imitate the new packaging.
-
The International Food Products business has achieved expansion by building its own sales channels. In the amino science domain, however, Ajinomoto seems to have lost the price wars with competitors even though you have prominently announced your development of innovative technologies. It seems you must still have some marketing issues to resolve. If you carry out a restructuring of the animal nutrition products business without reflecting on the past, isn’t the same thing likely to happen in the future? Are you confident that your entry into the flavorings business will not produce a similar result?
-
You have set a goal of becoming one of the top 10 global food makers. However, assuming the growth of other companies and the potential emergence of strong new rivals, I have difficulty understanding this relative position as a company goal. Wouldn’t it be better to set a more absolute and easy-to-understand goal?
-
I would like to ask about your capex plans. Strengthening horizontal expansion overseas will require you to use operating cash flow, but can you give us a better image of how much investment we should expect?
-
Are the current outside directors fully fulfilling their roles? If there are issues, what kinds of solutions might you be considering?
-
From December, you will begin disclosing on your homepage monthly data on Ajinomoto’s estimated average monthly market prices for three feed-use amino acids. However, I am concerned that this could lead to share price volatility caused by overseas investors' overreaction to commodity price trends. Disclosure is great, but rather than a singular emphasis on commodities, I would like you to come up with some original and ingenuous means for informing us about the status of your efforts in the specialty products. Wouldn’t that be more considerate of the needs of investors holding your stock as a long-term investment?
-
There are widely divergent views on MSG. For example, a major instant noodle maker has announced that that its noodles sold in the United States will be Non-MSG. This move is probably a good marketing tactic that will appeal to consumers who have a favorable view of Non-MSG products as more natural. Some domestic food manufacturers have also said that while they will use MSG in domestically sold products they are thinking of switching to a different marketing strategy overseas. How will you respond to such developments?
-
I have been struggling to understand the outlook for the international seasonings and processed foods business. In the first half of FY2016, sales were up 4% on a local-currency basis. I expect your next medium-term plan to aim for return to 10% growth, but given current circumstances that seems unrealistic to me. Specifically, what will you need to do to boost growth back to 10%? Canned coffee products are profitable overall but your differentiated products are not. I do not have a clear picture of how you can differentiate your products from those of Nestle. How do you expect to achieve 10% growth when you don’t have the top share even in the powdered drinks market?
-
Page 11 of the handout materials for the president’s presentation at the first-half results briefing shows little growth in the markets for both umami seasonings and flavor seasonings. I know Ajinomoto is making a best effort, but shouldn’t you be shifting more resources into menu seasonings and not just focusing marketing on umami and flavor seasonings?
-
It appears the tie-up with T.Hasegawa will enter the commercial production stage earlier than expected in FY2017. I think Ajinomoto has had a strong interest in the flavorings business for some time now, but do you also think the vanillin business presents interesting business prospects?
-
At the results briefing, you presented operating income forecasts based on your view of Ajinomoto from 2020 onward. You said you were aiming for operating income of ¥130.0–140.0 billion until FY2019 and an even higher level in FY2020. You also are appear to be targeting a rather high operating margin of 10%. Is this correct?
-
You appear to be assuming that around FY2019 you will achieve the goal of becoming one of the Top 10 global food makers, a goal that was prominently featured in the FY2014–2016 medium-term management plan. Can you tell me why it is so important for Ajinomoto to rank in the global Top 10?
-
Please tell us about the synergistic effects being generated by the consolidation of AGF, especially overseas synergies.
-
Regarding the international frozen foods business, Ajinomoto Windsor is reviewing SKU during FY2016. Although I have high expectations for the company from FY2017 onward, the current situation is not very clear. I would appreciate an update on AWI’s activities.
-
The domestic frozen foods market is very robust market. However, while some competitors posted double-digit sales growth, your growth was in the mid-single digits. What changes do you see in this market?
-
You have said that you will make Africa’s Promasidor a consolidated subsidiary. Are talks progressing? Also, please share with us the impact on topline that you expect from the synergistic effect of adding Promasidor to your African network.
-
At the results briefing, you mentioned an operating profit margin of 10% as one of the next medium-term plan’s targets and said that you wanted to make improvements to domestic production and logistics operations to ensure realization of that goal. Can you give us some specific measures that you are considering? Also, what kind of impact on future profits do you expect from the reforms of working styles that you are presently implementing?